DLCLHealthcare Service Provider
Dr Lalchandani Labs Ltd — PE Ratio & Valuation Analysis
₹14.81
+0.00%
Current P/E18.66xPrice to earnings
Industry P/E39.28xSector average
4Y Avg P/E11.8x58.1% above avg
✅
52.5% Discount to Industry
DLCL P/E 18.66x vs sector avg 39.28x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹1.43 | ₹17 | 11.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Dr Lalchandani Labs Ltd Valuation
Dr Lalchandani Labs Ltd (DLCL) currently trades at 18.66x earnings. The Healthcare Service Provider sector average PE is 39.28x. DLCL is trading at a discount to peers — may indicate relative value. Historically, DLCL has traded at an average PE of 11.8x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
3.08%
Dividend Yield
0.00%
More on Dr Lalchandani Labs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.